QDIS Blog

Mark Senak over at Eye on FDA posted about the possibility of a recess appointment for current acting FDA commissioner Andrew C. von Eschenbach. He makes some very good points and I tend to agree with him concerning the possible damage to the FDA if Dr. von Eschenbach should be appointed during a congressional recess.

By opinion though is the current administration really doesn’t care about that. The same argument applies to John Bolton and his appointment to the UN. I think there is a real possibility this will indeed happen especially since, as Mark point out, Dr. von Eschenbach has already resigned from his post at the NIH. I’m sure the administration has given him some sort of “guarantee” before he resigned form the NIH. I also think that if a recess appointment does occur, Dr. von Eschenbach will almost certainly be another short-time leader of the FDA. I really think this is too bad but that’s how I read the tea leaves at the current time.

Technorati Tags: FDA

Email Ed Vawter

Bookmark it with: | del.icio.us | Digg it | Furl | Simpy | Spurl | My Yahoo! |